DGIST researchers developed a deep learning model that classifies lung cancer exosomes based on physical properties measured by atomic force microscopy.
Key Details
- 1DGIST team used AFM to measure nanomechanical properties (stiffness, height-to-radius) of exosomes from NSCLC cell lines with different genetic mutations.
- 2AI model (DenseNet-121) classified exosomes by origin, achieving 96% accuracy and AUC of 0.92.
- 3Exosome stiffness reflected KRAS and EGFR mutations in their respective lung cancer cell lines.
- 4The method enables high-precision, label-free, liquid biopsy-based lung cancer diagnosis.
- 5Study published July 8, 2025, in Analytical Chemistry.
Why It Matters
This approach could offer a rapid, non-invasive way to diagnose lung cancer genetic mutations, reducing the need for tissue biopsies. Leveraging AI with nanomechanical imaging pushes boundaries in early cancer detection and personalized medicine.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.